Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Thompson

Showing results (41-50 of 484) with videos related to

Pageof 49
Sort By:
Nature Clinical Practice. Urology|June 10, 2006
Does prostate volume affect accurate grading of prostate biopsies?Ian M Thompson, Catherine M Tangen
Cancer Causes & Control : CCC|August 4, 2017
How will the 'cancer moonshot' impact health disparities?Amelie G Ramirez, Ian M Thompson
Current Opinion in Endocrinology, Diabetes, and Obesity|April 29, 2008
Androgens and prevention of prostate cancerJamey A Sarvis, Ian M Thompson
JAMA Oncology|July 17, 2015
Effect of 5α-Reductase Inhibitor Use on Mortality From Prostate CancerWilliam D Figg, Ian M Thompson
The Urologic Clinics of North America|July 12, 2002
Prevalence of complementary medicine in urologic practice. A review of recent studies with emphasis on use among prostate cancer patientsRobert A Zimmerman, Ian M Thompson
Urology|May 12, 2005
National cooperative group trialsRobert S Dipaola, Ian M Thompson
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 20, 2007
Prostate-specific antigen in the early detection of prostate cancerIan M Thompson, Donna P Ankerst
European Urology|December 27, 2011
The benefits of risk assessment tools for prostate cancerIan M Thompson, Donna P Ankerst
Urologic Oncology|December 1, 2007
Adjuvant radiotherapy for high-risk patients following radical prostatectomyGregory P Swanson, Ian M Thompson
The Journal of Urology|January 16, 2007
Understanding mixed messages about prostate specific antigen: biases in the evaluation of cancer biomarkersDonna Pauler Ankerst, Ian M Thompson
Pageof 49

Showing results (41-50 of 484) with videos related to

Sort By:
Pageof 49
Nature Clinical Practice. Urology|June 10, 2006
Does prostate volume affect accurate grading of prostate biopsies?Ian M Thompson, Catherine M Tangen
Cancer Causes & Control : CCC|August 4, 2017
How will the 'cancer moonshot' impact health disparities?Amelie G Ramirez, Ian M Thompson
Current Opinion in Endocrinology, Diabetes, and Obesity|April 29, 2008
Androgens and prevention of prostate cancerJamey A Sarvis, Ian M Thompson
JAMA Oncology|July 17, 2015
Effect of 5α-Reductase Inhibitor Use on Mortality From Prostate CancerWilliam D Figg, Ian M Thompson
The Urologic Clinics of North America|July 12, 2002
Prevalence of complementary medicine in urologic practice. A review of recent studies with emphasis on use among prostate cancer patientsRobert A Zimmerman, Ian M Thompson
Urology|May 12, 2005
National cooperative group trialsRobert S Dipaola, Ian M Thompson
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 20, 2007
Prostate-specific antigen in the early detection of prostate cancerIan M Thompson, Donna P Ankerst
European Urology|December 27, 2011
The benefits of risk assessment tools for prostate cancerIan M Thompson, Donna P Ankerst
Urologic Oncology|December 1, 2007
Adjuvant radiotherapy for high-risk patients following radical prostatectomyGregory P Swanson, Ian M Thompson
The Journal of Urology|January 16, 2007
Understanding mixed messages about prostate specific antigen: biases in the evaluation of cancer biomarkersDonna Pauler Ankerst, Ian M Thompson
Pageof 49